SCHEMBL4459730

SCHEMBL4459730

Nc1cccc(-c2ccn(Cc3ccccc3)n2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.55
LMNA P02545 6/20 0.52
ALDH1A1 P00352 6/20 0.52
KDM4E B2RXH2 5/20 0.52
HPGD P15428 5/20 0.52
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.47
MAPT P10636 6/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
TEK Q02763 2/20 0.46
KDR P35968 1/20 0.46
HTT P42858 1/20 0.46
TDP1 Q9NUW8 2/20 0.44
MAOA P21397 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25295323 0.86 MPO (0.48) MPOLMNAALDH1A1KDM4EHPGD
SCHEMBL30509990 0.86 MPO (0.48) MPOLMNAALDH1A1KDM4EHPGD
SCHEMBL30509994 0.86 MPO (0.48) MPOLMNAALDH1A1KDM4EHPGD
SCHEMBL7494123 0.84 RAB9A (0.68) MPOLMNAALDH1A1KDM4EHPGD
SCHEMBL25252926 0.82 MAPT (0.59) MPOLMNAALDH1A1KDM4EHPGD
SCHEMBL18586550 0.81 MPO (0.66) MPOLMNAALDH1A1KDM4EHPGD
SCHEMBL29033970 0.80 KDM4E (0.50) MPOLMNAALDH1A1KDM4EHPGD
SCHEMBL30502863 0.80 KDM4E (0.50) MPOLMNAALDH1A1KDM4EHPGD
SCHEMBL25379052 0.79 KDM4E (0.52) MPOLMNAALDH1A1KDM4EHPGD
SCHEMBL30502865 0.79 MPO (0.47) MPOLMNAALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009090548-A2 3-AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-07-23 WO disclosed